annual

Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Society 2025 Annual MeetingApplied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting

Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting

 Slowing of progression of disease observed via MRI at 24 months Improvements in outcomes and reduction in sorbitol maintained through…

19 hours ago
Tessera Therapeutics Features New Preclinical Data Demonstrating Progress Across its In Vivo Gene WritingPrograms and Delivery Platform at the American Society of Gene and Cell Therapy 28th Annual MeetingTessera Therapeutics Features New Preclinical Data Demonstrating Progress Across its In Vivo Gene WritingPrograms and Delivery Platform at the American Society of Gene and Cell Therapy 28th Annual Meeting

Tessera Therapeutics Features New Preclinical Data Demonstrating Progress Across its In Vivo Gene WritingPrograms and Delivery Platform at the American Society of Gene and Cell Therapy 28th Annual Meeting

May 17, 2025 06:00 ET  | Source: Tessera Therapeutics Presented new preclinical data in non-human primates (NHP) for alpha-1 antitrypsin…

2 days ago
Metagenomi Presents Data Highlighting Advancements in Next-Generation Genome Editing Technologies at ASGCT Annual Meeting 2025Metagenomi Presents Data Highlighting Advancements in Next-Generation Genome Editing Technologies at ASGCT Annual Meeting 2025

Metagenomi Presents Data Highlighting Advancements in Next-Generation Genome Editing Technologies at ASGCT Annual Meeting 2025

- Potential best-in-class extrahepatic in vivo gene editing with all-in-one delivery to the central nervous system (CNS) is a critical…

5 days ago
Preclinical insights into dosing for first-in-human in vivo liver-directed gene therapy for MMA delivered in an oral presentation at the ASGCT Annual MeetingPreclinical insights into dosing for first-in-human in vivo liver-directed gene therapy for MMA delivered in an oral presentation at the ASGCT Annual Meeting

Preclinical insights into dosing for first-in-human in vivo liver-directed gene therapy for MMA delivered in an oral presentation at the ASGCT Annual Meeting

PRESS RELEASEPreclinical insights into dosing for first-in-human in vivo liver-directed gene therapy for MMA delivered in an oral presentation at…

5 days ago
AGM Group Holdings Inc. Files 2024 Annual Report on Form 20-FAGM Group Holdings Inc. Files 2024 Annual Report on Form 20-F

AGM Group Holdings Inc. Files 2024 Annual Report on Form 20-F

Beijing, May 13, 2025 (GLOBE NEWSWIRE) -- AGM Group Holdings Inc. (“AGM Holdings” or the “Company”) (NASDAQ: AGMH), an integrated…

6 days ago
Empowering New Industrialization, XCMG Machinery’s 2024 Annual Report Highlights High-Quality DevelopmentEmpowering New Industrialization, XCMG Machinery’s 2024 Annual Report Highlights High-Quality Development

Empowering New Industrialization, XCMG Machinery’s 2024 Annual Report Highlights High-Quality Development

XUZHOU, China, May 13, 2025 /PRNewswire/ -- XCMG Machinery ("XCMG", SHE:000425), a global leader in construction machinery, has published its…

6 days ago
Applied Therapeutics Announces Acceptance of Late-Breaking Abstract for Oral Presentation at the Peripheral Nerve Society 2025 Annual MeetingApplied Therapeutics Announces Acceptance of Late-Breaking Abstract for Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting

Applied Therapeutics Announces Acceptance of Late-Breaking Abstract for Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting

Late-breaking oral presentation to include full 12-month clinical data from INSPIRE registrational Phase 3 trial in addition to topline 18-month…

1 week ago
Invitation to attend the annual and the extraordinary shareholders meetings of the Company to be held on June 11, 2025Invitation to attend the annual and the extraordinary shareholders meetings of the Company to be held on June 11, 2025

Invitation to attend the annual and the extraordinary shareholders meetings of the Company to be held on June 11, 2025

REGULATED INFORMATIONMay 9, 2025, 7:00am CET / 1:00am ET NYXOAH SA(Euronext Brussels: NYXH) Rue Edouard Belin 12, 1435 Mont-Saint-Guibert, Belgium(hereinafter…

1 week ago
Annual NMDP(SM) Gala in New York City Raises Over a Half Million Dollars, Enabling More Patients to Receive Life-Saving Cell TherapyAnnual NMDP(SM) Gala in New York City Raises Over a Half Million Dollars, Enabling More Patients to Receive Life-Saving Cell Therapy

Annual NMDP(SM) Gala in New York City Raises Over a Half Million Dollars, Enabling More Patients to Receive Life-Saving Cell Therapy

May 06, 2025 14:06 ET  | Source: NMDP MINNEAPOLIS, May 06, 2025 (GLOBE NEWSWIRE) -- NMDPSM hosted its annual gala…

2 weeks ago